NPC
TEVA icon

National Planning Corporation’s Teva Pharmaceuticals TEVA Stock Holding History

National Planning Corporation’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,717
Closed -$274K – 725
2016
Q3 		$274K Sell
6,717
-410
-6% -$21.4K 0.02% 503
2016
Q2 		$377K Buy
7,127
+150
+2% +$7.99K 0.03% 439
2016
Q1 		$351K Sell
6,977
-3,275
-32% -$192K 0.03% 440
2015
Q4 		$603K Buy
10,252
+4,025
+65% +$249K 0.05% 350
2015
Q3 		$383K Hold
6,227
– – 0.04% 400
2015
Q2 		$433K Buy
6,227
+109
+2% +$6.72K 0.04% 391
2015
Q1 		$376K Sell
6,118
-3,800
-38% -$221K 0.03% 428
2014
Q4 		$568K Buy
9,918
+253
+3% +$14.1K 0.04% 369
2014
Q3 		$531K Sell
9,665
-98
-1% -$5.19K 0.04% 383
2014
Q2 		$512K Buy
9,763
+1,812
+23% +$92.6K 0.04% 387
2014
Q1 		$424K Buy
7,951
+456
+6% +$21.1K 0.04% 426
2013
Q4 		$299K Sell
7,495
-395
-5% -$15.6K 0.03% 520
2013
Q3 		$300K Buy
7,890
+1,216
+18% +$47.4K 0.03% 488
2013
Q2 		$263K Buy
+6,674
New +$260K 0.03% 418

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

National Planning Corporation's TEVA Position: Q4 2016 in Review

National Planning Corporation sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 6,717 shares — an estimated $274K sold.

National Planning Corporation first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $603K in Q4 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • National Planning Corporation reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • National Planning Corporation sold 6,717 Teva Pharmaceuticals shares in Q4 2016, an estimated $274K.
  • National Planning Corporation first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • National Planning Corporation's Teva Pharmaceuticals position peaked at $603K in Q4 2015.
  • 737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on National Planning Corporation's 13F filing for Q4 2016, filed 7 Feb 2017.